Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed
Public ClinicalTrials.gov record NCT02603120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching From a Regimen of Dolutegravir and ABC/3TC, or a Fixed Dose Combination (FDC) of ABC/DTG/3TC to a FDC of GS-9883/F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of switching from a regimen of dolutegravir (DTG) and abacavir/lamivudine (ABC/3TC) or a fixed dose combination (FDC) of abacavir/dolutegravir/lamivudine (ABC/DTG/3TC) to a FDC of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus continuing DTG and ABC/3TC as the FDC ABC/DTG/3TC in virologically suppressed Human Immunodeficiency Virus- 1 (HIV-1) infected adults.
Study identification
- NCT ID
- NCT02603120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 567 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 10, 2015
- Primary completion
- May 8, 2017
- Completion
- Oct 22, 2019
- Last update posted
- Nov 11, 2020
2015 – 2019
United States locations
- U.S. sites
- 61
- U.S. states
- 22
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85012 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90069 | — |
| Not listed | Oakland | California | 94602 | — |
| Not listed | Oakland | California | 94609 | — |
| Not listed | Palm Springs | California | 92264 | — |
| Not listed | Sacramento | California | 95187 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Leandro | California | 94577 | — |
| Not listed | Washington D.C. | District of Columbia | 20009 | — |
| Not listed | Washington D.C. | District of Columbia | 20036 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Fort Lauderdale | Florida | 33316 | — |
| Not listed | Ft. Pierce | Florida | 34982 | — |
| Not listed | Miami | Florida | 33133 | — |
| Not listed | Miami Beach | Florida | 33139 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Pensacola | Florida | 32504 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Vero Beach | Florida | 32960 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Wilton Manors | Florida | 33305 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Macon | Georgia | 31201 | — |
| Not listed | Savannah | Georgia | 31401 | — |
| Not listed | Honolulu | Hawaii | 96813 | — |
| Not listed | Chicago | Illinois | 60613 | — |
| Not listed | Chicago | Illinois | 60657 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Boston | Massachusetts | 02118-2393 | — |
| Not listed | Springfield | Massachusetts | 01105 | — |
| Not listed | Berkley | Michigan | 48072 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Minneapolis | Minnesota | 55415 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | St Louis | Missouri | 63139 | — |
| Not listed | Newark | New Jersey | 07102 | — |
| Not listed | Santa Fe | New Mexico | 87505 | — |
| Not listed | Buffalo | New York | 14215 | — |
| Not listed | New York | New York | 10011 | — |
| Not listed | The Bronx | New York | 10467-2490 | — |
| Not listed | Charlotte | North Carolina | 28207 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | Huntersville | North Carolina | 28078 | — |
| Not listed | Cincinnati | Ohio | 45267-0560 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Columbia | South Carolina | 29203-6840 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Dallas | Texas | 75219 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77098 | — |
| Not listed | Longview | Texas | 75605 | — |
| Not listed | Seattle | Washington | 98104 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02603120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2020 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02603120 live on ClinicalTrials.gov.